Nuveen’s Minerva Neurosciences NERV Stock Holding History

Nuveen’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	+45,478	New	+$247K	﹤0.01%	3561
2021 Q2	–	Sell	-15,335	Closed	-$1.65M	–	3481
2021 Q1	$1.65M	Sell	15,335 -406	-3%	-$10.1K	﹤0.01%	2701
2020 Q4	$1.7M	Buy	15,741 +141	+0.9%	+$3.55K	﹤0.01%	2587
2020 Q3	$1.68M	Sell	15,600 -16,607	-52%	-$449K	﹤0.01%	2466
2020 Q2	$3.47M	Sell	32,207 -18,346	-36%	-$1.08M	﹤0.01%	2086
2020 Q1	$2.43M	Buy	50,553 +36,211	+252%	+$2.18M	﹤0.01%	2094
2019 Q4	$815K	Sell	14,342 -11,534	-45%	-$509K	﹤0.01%	2754
2019 Q3	$1.6M	Buy	25,876 +825	+3%	+$46.7K	﹤0.01%	2500
2019 Q2	$1.13M	Buy	+25,051	New	+$1.25M	﹤0.01%	2686

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nuveen's NERV Position: Q2 2026 in Review

Nuveen opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 45,478 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #3561 among its holdings. This is a return to the name: Nuveen previously reported a position in NERV as recently as Q1 2021.

Nuveen first reported a position in NERV in Q2 2019 and has held it in 9 quarters since. The position peaked at $3.47M in Q2 2020. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

Nuveen held 45,478 shares of Minerva Neurosciences worth $252K as of Q2 2026.
Minerva Neurosciences was a new Nuveen position in Q2 2026.
Minerva Neurosciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3561 holding.
Nuveen first reported a position in Minerva Neurosciences in Q2 2019 and has held it in 9 quarters since.
Nuveen's Minerva Neurosciences position peaked at $3.47M in Q2 2020.
60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.